Literature DB >> 24009358

Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses.

Yi Shi1, Wei Zhang, Fei Wang, Jianxun Qi, Ying Wu, Hao Song, Feng Gao, Yuhai Bi, Yanfang Zhang, Zheng Fan, Chengfeng Qin, Honglei Sun, Jinhua Liu, Joel Haywood, Wenjun Liu, Weimin Gong, Dayan Wang, Yuelong Shu, Yu Wang, Jinghua Yan, George F Gao.   

Abstract

An avian-origin human-infecting influenza (H7N9) virus was recently identified in China. We have evaluated the viral hemagglutinin (HA) receptor-binding properties of two human H7N9 isolates, A/Shanghai/1/2013 (SH-H7N9) (containing the avian-signature residue Gln(226)) and A/Anhui/1/2013 (AH-H7N9) (containing the mammalian-signature residue Leu(226)). We found that SH-H7N9 HA preferentially binds the avian receptor analog, whereas AH-H7N9 HA binds both avian and human receptor analogs. Furthermore, an AH-H7N9 mutant HA (Leu(226) → Gln) was found to exhibit dual receptor-binding property, indicating that other amino acid substitutions contribute to the receptor-binding switch. The structures of SH-H7N9 HA, AH-H7N9 HA, and its mutant in complex with either avian or human receptor analogs show how AH-H7N9 can bind human receptors while still retaining the avian receptor-binding property.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24009358     DOI: 10.1126/science.1242917

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  121 in total

1.  Amino Acid Substitutions That Affect Receptor Binding and Stability of the Hemagglutinin of Influenza A/H7N9 Virus.

Authors:  Eefje J A Schrauwen; Mathilde Richard; David F Burke; Guus F Rimmelzwaan; Sander Herfst; Ron A M Fouchier
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

2.  The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.

Authors:  Netanel Tzarum; Robert P de Vries; Wenjie Peng; Andrew J Thompson; Kim M Bouwman; Ryan McBride; Wenli Yu; Xueyong Zhu; Monique H Verheije; James C Paulson; Ian A Wilson
Journal:  Cell Rep       Date:  2017-04-11       Impact factor: 9.423

3.  Unique Structural Features of Influenza Virus H15 Hemagglutinin.

Authors:  Netanel Tzarum; Ryan McBride; Corwin M Nycholat; Wenjie Peng; James C Paulson; Ian A Wilson
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

4.  Solving the mystery of H7N9 by crystal balls.

Authors:  Kwok-Yung Yuen
Journal:  Cell Res       Date:  2013-11-12       Impact factor: 25.617

5.  Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.

Authors:  Nicholas C Wu; Jia Xie; Tianqing Zheng; Corwin M Nycholat; Geramie Grande; James C Paulson; Richard A Lerner; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2017-06-14       Impact factor: 21.023

6.  Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.

Authors:  Cong Chen; Liguo Liu; Yan Xiao; Sheng Cui; Jianmin Wang; Qi Jin
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 7.  Structural insights into the design of novel anti-influenza therapies.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2018-02-02       Impact factor: 15.369

8.  Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses.

Authors:  Gabriele Neumann; Catherine A Macken; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors.

Authors:  Heng Zhang; Robert P de Vries; Netanel Tzarum; Xueyong Zhu; Wenli Yu; Ryan McBride; James C Paulson; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

10.  Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus.

Authors:  Netanel Tzarum; Robert P de Vries; Xueyong Zhu; Wenli Yu; Ryan McBride; James C Paulson; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.